4//SEC Filing
GERAGHTY JAMES A 4
Accession 0001415889-22-006940
CIK 0000861838other
Filed
Jun 26, 8:00 PM ET
Accepted
Jun 27, 4:30 PM ET
Size
5.9 KB
Accession
0001415889-22-006940
Insider Transaction Report
Form 4
GERAGHTY JAMES A
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-06-23+26,000→ 26,000 totalExercise: $0.46From: 2023-06-23Exp: 2032-06-23→ Common Stock (26,000 underlying)
Footnotes (2)
- [F1]Non-qualified stock options granted, under the Issuer's 2013 Stock Incentive Plan, on the date of the Issuer's 2022 annual meeting of stockholders at an exercise price equal to the closing price of the Issuer's common stock on the date of grant, pursuant to the Issuer's director compensation policy.
- [F2]The options vest in full and become immediately exercisable on June 23, 2023 (first anniversary of the date of grant), subject to continued service as a director of the Issuer.
Documents
Issuer
IDERA PHARMACEUTICALS, INC.
CIK 0000861838
Entity typeother
Related Parties
1- filerCIK 0001239746
Filing Metadata
- Form type
- 4
- Filed
- Jun 26, 8:00 PM ET
- Accepted
- Jun 27, 4:30 PM ET
- Size
- 5.9 KB